Akoya Biosciences Inc Revenue Growth Rates (AKYA), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Akoya Biosciences Inc   (NASDAQ: AKYA)
 

AKYA's Revenue Growth by Quarter and Year

Akoya Biosciences Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AKYA Revenue (in millions $) FY 2025 FY 2024 FY 2023 FY 2022
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 15.87
FY 15.87





AKYA Revenue first quarter 2025 Y/Y Growth Comment
Akoya Biosciences Inc reported decrease in Revenue in the first quarter 2025 by -8.68% to $ 15.87 millions, from the same quarter in 2024.
The decrease in the first quarter 2025 Akoya Biosciences Inc 's Revenue compares unfavorably to the Company's average Revenue increase of 18.3%.

Looking into first quarter 2025 results within Laboratory Analytical Instruments industry 19 other companies have achieved higher Revenue growth. While Akoya Biosciences Inc ' s Revenue decline of -8.68% ranks overall at the positon no. 3216 in the first quarter 2025.


AKYA Revenue ( Y/Y Growth %) 2025
 2024 2023 2022
4th Quarter December - -15.48 % 24.84 % 31.31 %
3rd Quarter September - -22.9 % 28.81 % 39.84 %
2nd Quarter June - -3.16 % 29.23 % 36.88 %
1st Quarter March -8.68 % -18.82 % 26.76 % 38.33 %
FY   - -15.13 % 27.32 % -

Financial Statements
Akoya Biosciences Inc 's first quarter 2025 Revenue $ 15.87 millions AKYA's Income Statement
Akoya Biosciences Inc 's first quarter 2024 Revenue $ 17.38 millions Quarterly AKYA's Income Statement


AKYA Revenue (Quarter on Quarter Growth %)

 2025
 2024 2023 2022
4th Quarter December - 19.6 % 9.1 % 12.57 %
3rd Quarter September - -16.39 % 5.02 % 5.37 %
2nd Quarter June - 28.83 % 7.99 % 5.92 %
1st Quarter March -29.12 % -34.39 % 0.9 % 4.52 %
FY (Year on Year)   - -15.13 % 27.32 % -


Back to AKYA Growth rate Comparisons >> Back to AKYA Growth rate Comparisons >>


Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #20
Healthcare Sector #459
Overall #3216

Revenue Y/Y Growth Statistics
High Average Low
52.7 % 18.3 % -22.87 %
(Dec 31 2022)   (Dec 31 2024)
Revenue first quarter 2025 Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #20
Healthcare Sector #459
Overall #3216
Revenue Y/Y Growth Statistics
High Average Low
52.7 % 18.3 % -22.87 %
(Dec 31 2022)   (Dec 31 2024)

Revenue by Quarter for the Fiscal Years 2022, 2023, 2024, 2025

Akoya Biosciences Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
29.68 % 3.41 % -34.39 %
(Dec 31 2020)  


AKYA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2025 Akoya Biosciences Inc disclosed fall in Revenue from the fourth quarter by -29.12% to $ 15.87 millions, from $ 22.39 millions achived in the previous reporting period.

But that's not important problem, as Akoya Biosciences Inc 's Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 21 other companies have achieved higher Revenue quarter on quarter growth. While Akoya Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 3650.


Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #22
Healthcare Sector #513
Overall #3650
Revenue Q/Q Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry #22
Healthcare Sector #513
Overall #3650
Revenue Q/Q Growth Statistics
High Average Low
29.68 % 3.41 % -34.39 %
(Dec 31 2020)  


AKYA's I. Quarter Q/Q Revenue Comment
In the I. Quarter 2025 Akoya Biosciences Inc disclosed fall in Revenue from the fourth quarter by -29.12% to $ 15.87 millions, from $ 22.39 millions achived in the previous reporting period.

But that's not important problem, as Akoya Biosciences Inc 's Revenue generally seem to plunge in this quarter.

Within Laboratory Analytical Instruments industry 21 other companies have achieved higher Revenue quarter on quarter growth. While Akoya Biosciences Inc 's Revenue growth quarter on quarter, overall rank is 3650.


Akoya Biosciences Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Mar 31 2025)		 12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)
Cumulative Revenue 12 Months Ending $ 79.37 $ 80.88 $ 84.98 $ 90.53 $ 91.26
Y / Y Revenue Growth (TTM) -13.03 % -15.12 % -5.6 % 7.01 % 14.97 %
Year on Year Revenue Growth Overall Ranking # 861 # 407 # 303 # 267 # 234
Seqeuential Revenue Change (TTM) -1.86 % -4.82 % -6.13 % -0.8 % -4.23 %
Seq. Revenue Growth (TTM) Overall Ranking # 2779 # 1441 # 1164 # 1138 # 961


Cumulative Revenue growth Comment
Akoya Biosciences Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2024. If the fiscal year would end in Mar 31 2025, Akoya Biosciences Inc 's annual Revenue decline would be -13.03% year on year to $79 millions.

In the Healthcare sector 191 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 407 to 861.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 18
Healthcare Sector # 192
Overall # 861

Revenue TTM Y/Y Growth Statistics
High Average Low
36.31 %
 14.37 %
-13.03 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 397
S&P 500 # 2779
Cumulative Revenue growth Comment
Akoya Biosciences Inc showed decline, but improvement compare to trailing twelve month Revenue decrease in Dec 31 2024. If the fiscal year would end in Mar 31 2025, Akoya Biosciences Inc 's annual Revenue fall would be -13.03% year on year to $79 millions.

In the Healthcare sector 191 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 407 to 861.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Laboratory Analytical Instruments Industry # 18
Healthcare Sector # 192
Overall # 861

Revenue TTM Y/Y Growth Statistics
High Average Low
36.31 %
14.37 %
-13.03 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 18
Sector # 397
S&P 500 # 2779




Other Revenue Growth
Laboratory Analytical Instruments Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
AKYA's Revenue Growth Ratio versus Laboratory Analytical Instruments Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue fall for the quarter ending Mar 31 2025 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2025
Carlisle Companies Incorporated-0.06%$ -0.064 millions
Henry Schein Inc -0.13%$ -0.126 millions
Tactile Systems Technology Inc -0.14%$ -0.137 millions
Alpha Pro Tech Ltd -0.19%$ -0.186 millions
Premier Air Charter Holdings Inc -0.20%$ -0.204 millions
Gilead Sciences Inc -0.28%$ -0.284 millions
Adm Tronics Unlimited Inc -0.32%$ -0.315 millions
Jazz Pharmaceuticals Plc-0.46%$ -0.459 millions
Milestone Scientific Inc -0.73%$ -0.730 millions
Logicmark Inc-0.74%$ -0.738 millions
Yunhong Green Cti Ltd -0.74%$ -0.745 millions
Amphastar Pharmaceuticals Inc -0.76%$ -0.761 millions
Enhabit Inc -0.95%$ -0.953 millions
Elanco Animal Health Incorporated-1.00%$ -0.996 millions
3m Company-1.03%$ -1.031 millions
Envista Holdings Corporation-1.17%$ -1.171 millions
Globus Medical Inc -1.41%$ -1.409 millions
Proqr Therapeutics N v -1.53%$ -1.528 millions
Merck and Co Inc -1.56%$ -1.559 millions
Icad Inc-1.61%$ -1.615 millions
Fortrea Holdings Inc -1.63%$ -1.631 millions
Align Technology inc -1.78%$ -1.776 millions
Adapthealth Corp -1.84%$ -1.844 millions
Sunlink Health Systems Inc -2.05%$ -2.050 millions
Tonix Pharmaceuticals Holding Corp -2.14%$ -2.135 millions
Alpha Teknova Inc -2.19%$ -2.194 millions
Quidelortho Corp-2.56%$ -2.560 millions
Teladoc Health Inc -2.59%$ -2.594 millions
Tenet Healthcare Corp-2.70%$ -2.701 millions
Charles River Laboratories International inc -2.71%$ -2.708 millions


About Akoya Biosciences Inc Revenue Growth Rates (AKYA), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Akoya Biosciences Inc (CIK 1711933).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001558370-25-007462
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Akoya Biosciences Inc ’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.